| abstract |
The present invention is at least two per unit of glucopyranose, useful as an active ingredient for the treatment and / or prevention of degenerative arthritis, osteoarthritis, arthrosis, arthrosis or degenerative arthritis, or for the treatment of heparin-induced thrombocytopenia, or for cartilage repair or connective tissue repair. A novel beta-cyclodextrin polysulfate compound comprising 3 sulfate groups and 1 to 3 2-carboxyethyl substituents. |